| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 95,125 | 95,033 | 99,381 | 109,326 | | Cost of Revenue | 38,728 | 39,164 | 45,214 | 46,488 | | | Gross Profit | 56,397 | 55,869 | 54,167 | 62,838 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 53,504 | 52,401 | 63,084 | 63,632 | | Non Recurring | 23 | 42 | 49 | 4,009 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,870 | 3,426 | (8,966) | (4,803) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 110 | 51 | 725 | (8) | | Earnings Before Interest And Taxes | 2,980 | 3,477 | (8,241) | (4,811) | | Interest Expense | 132 | 268 | 74 | 99 | | Income Before Tax | 2,848 | 3,209 | (8,315) | (4,910) | | Income Tax Expense | 1,327 | 1,313 | (2,396) | 507 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,521 | 1,896 | (5,919) | (5,417) | | | Non-recurring Events | | Discontinued Operations | (18) | (49) | (29) | (8) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,503 | 1,847 | (5,948) | (5,425) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,503 | $1,847 | ($5,948) | ($5,425) |
|
0.01% Nasdaq 0.00%
Income Statement
